An adverse relationship between genetics and immune response
Studies by researchers at DZNE Tübingen shine new light on the mechanisms of Parkinson’s disease
Parkinson’s is a brain disease…
Darmgesundheit und Gehirnerkrankungen: Forschungsprojekt startet am DZNE Tübingen
Deutschland wird in den kommenden Jahrzehnten einen grundlegenden demografischen Wandel erfahren. Damit nimmt auch…
Studies on the “gut-brain axis”: Bonn and Tübingen receive 1.5 million US dollars each in funding
Studies on the “gut-brain axis”: Bonn and Tübingen receive 1.5 million US dollars each in…
COVID-19: Release of immature blood cells from bone marrow as a signature of severe disease
In severe cases of COVID-19 disease, not only classic immune cells play a role. In particular, the release…
Highly cited: Seven DZNE experts among the world’s most influential researchers
Researchers whose studies are widely quoted in scientific journals are considered influential – because a quotation…
Novel technologies assisting people with dementia
In Europe, about 10 million people are living with dementia and this is expected to double by 2050. Most people affected by this condition want to…
Deutsche Demenzhilfe verliert überzeugten Förderer
Mit dem Tod des ehemaligen Ministerpräsidenten NRW Wolfgang Clement verlieren die Stiftung Deutsche Demenzhilfe und das DZNE einen starken…
In “Nature Neuroscience”, researchers from the DZNE and the Hertie Institute for Clinical Brain Research present new findings on the early development of Alzheimer's disease.
Joint press release of…
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
